ARCHIVES

DeVita Considers Laetrile Tests

This article is from The Cancer Letter archive.

Vol. 03 No. 22 | June 3, 1977

Download PDF Visit The Full Archive

Related Articles

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

NCI To Recomplete CIDAC Contracts

September 23, 1977

In Brief: Move To NCI director’s Office gives Greater Visibility To NCI Liaison Office

September 13, 1996

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012